Acceptability/Feasibility Testing of SCAR
NCT04859790 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2021-09-09
Summary
Social anxiety disorder (SAD) is a prominent mental health burden, affecting more than 24 million Americans annually. Social anxiety is worsened by social isolation and severe, ongoing stress. Therefore, it is expected that the COVID-19 pandemic will significantly increase social anxiety symptoms and related impairment. Left untreated, social anxiety typically has a chronic course and a substantial impact on wellbeing. Despite the considerable impact of social anxiety, treatment for social anxiety is underutilized compared to other anxiety disorders, likely due to the distress socially anxious individuals experience upon presenting to treatment. Thus, treatments that are accessible and effective in treating social anxiety are needed. One potential to augment existing treatments for SAD is to develop brief, single-session interventions that could be administered virtually. These interventions could then be combined with additional technological innovations, such as ecological momentary intervention (EMI), to reduce social anxiety. Further, interventions targeting causal risk factors for social anxiety may be particularly beneficial, as these approaches could be used in both prevention and treatment efforts. One risk factor that represents an ideal target for interventions is anxiety sensitivity social concerns (ASSC), defined as the fear of publicly observable symptoms of anxiety (i.e., blushing, trembling, sweating). Although ASSC has been shown to be a risk factor for social anxiety, no interventions have been developed to target ASSC. In the proposed study, a brief (1 hour) virtual intervention targeting ASSC using Cognitive-Behavioral Therapy (CBT) techniques will be developed through examining the acceptability and feasibility of the SCAR intervention prototype. The proposed project holds the promise of developing an intervention to reliably reduce the impact of ASSC, both as a standalone intervention and in combination with other therapeutic approaches.
Conditions
- Social Anxiety
Interventions
- BEHAVIORAL
-
Social Concerns Appraisal Retraining
SCAR consists of an hour-long intervention session, followed by a 2-week-long EMI. During the hour-long intervention session, participants will receive psychoeducation (e.g., defining common terms like anxiety), discuss popular misconceptions they may have about publicly observable anxiety symptoms (e.g., "people can tell I'm anxious by looking at me"), and complete exposure exercises (e.g., practicing facing feared physical sensations such as sweating). During the EMI, participants will report on their social anxiety symptoms four times per day. When participants endorse elevated social anxiety during this time, they will receive a targeted message reminding them of the topics covered in the intervention session.
Sponsors & Collaborators
-
Ohio University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- United States
Study Locations
More Related Trials
-
Social Anxiety Virtual Reality Study
NCT04288180 ·Status: TERMINATED
-
Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".
NCT04902066 ·Status: COMPLETED ·Phase: NA
-
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
NCT05683223 ·Status: RECRUITING ·Phase: NA
-
Gaze Contingent Feedback in Social Anxiety Disorder
NCT02590770 ·Status: COMPLETED ·Phase: NA
-
Ketamine Infusion for Social Anxiety Disorder
NCT02083926 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
iExposure Intervention for Social Anxiety
NCT06409247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Social Support and Enhanced Fear Extinction
NCT04565041 ·Status: RECRUITING ·Phase: NA
-
Arousal Training for Social Anxiety Disorder
NCT02493010 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
NCT00294346 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of ONO-1110 in Patients With Social Anxiety Disorder
NCT06805565 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Group Exposure Workshops for Socially Anxious Undergraduates
NCT06673407 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia
NCT04850989 ·Status: COMPLETED ·Phase: NA
-
Specifying and Treating Anxiety in Autism Research
NCT03279471 ·Status: COMPLETED ·Phase: PHASE2
-
Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
NCT06526260 ·Status: RECRUITING ·Phase: NA
-
oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder
NCT05576259 ·Status: COMPLETED ·Phase: NA
-
Using Virtual Reality in Exposure-Based Treatment for Social Anxiety in Youth
NCT03135990 ·Status: TERMINATED ·Phase: NA
-
Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders
NCT03033056 ·Status: COMPLETED
-
Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety
NCT03346239 ·Status: COMPLETED ·Phase: NA
-
Online Radical Acceptance Intervention for Social Anxiety Disorder
NCT07325929 ·Status: RECRUITING ·Phase: NA
-
Virtual Reality for AnxIety Disorders - Randomized Controlled Trial
NCT05302518 ·Status: COMPLETED ·Phase: NA
-
Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
NCT06693609 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder
NCT02432703 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCD
NCT03476902 ·Status: COMPLETED ·Phase: NA
-
Augmentation Study of A Computerized Treatment for Social Anxiety Disorder
NCT02372019 ·Status: COMPLETED ·Phase: NA
-
Examining Long-Term Effects and Neural Mediators of Behavioral Treatments for Social Anxiety Disorder
NCT00872820 ·Status: COMPLETED ·Phase: NA